381
Views
6
CrossRef citations to date
0
Altmetric
Review

Triplet therapies – the new standard of care for multiple myeloma: how to manage common toxicities

, , &
Pages 957-973 | Received 17 Jun 2018, Accepted 17 Oct 2018, Published online: 04 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Albert Oriol, Alessandra Larocca, Xavier Leleu, Roman Hajek, Hani Hassoun, Paula Rodríguez-Otero, Agne Paner, Fredrik H. Schjesvold, Joachim Gullbo & Paul G. Richardson. (2020) Melflufen for relapsed and refractory multiple myeloma. Expert Opinion on Investigational Drugs 29:10, pages 1069-1078.
Read now

Articles from other publishers (5)

Phoebe K. Mondala, Ashni A. Vora, Tianyuan Zhou, Elisa Lazzari, Luisa Ladel, Xiaolin Luo, Youngsoo Kim, Caitlin Costello, A. Robert MacLeod, Catriona H.M. Jamieson & Leslie A. Crews. (2021) Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption. Cell Stem Cell 28:4, pages 623-636.e9.
Crossref
Joseph Tariman, Craig Klugman, Kashica Webber-Ritchey & Kim Amer. (2021) Care Delivery and Treatment Decision Making: Bioethical and Nursing Considerations During and After the COVID-19 Pandemic. Clinical Journal of Oncology Nursing 25:1, pages 61-68.
Crossref
Olivier Mozziconacci, Natalia Subelzu, Christian Schöneich, Yong Liu, Andreas Abend & W. Peter Wuelfing. (2020) Probing Protein Conformation Destabilization in Sterile Liquid Formulations through the Formation of 3,4-Dihydroxyphenylalanine. Molecular Pharmaceutics 17:10, pages 3783-3793.
Crossref
María-Victoria Mateos, Joan Bladé, Sara Bringhen, Enrique M Ocio, Yvonne Efebera, Luděk Pour, Francesca Gay, Pieter Sonneveld, Joachim Gullbo & Paul G. Richardson. (2020) Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma. Journal of Clinical Medicine 9:10, pages 3120.
Crossref
Crystal Antoine-Pepeljugoski & Marc Justin Braunstein. (2019) Management of Newly Diagnosed Elderly Multiple Myeloma Patients. Current Oncology Reports 21:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.